X4 PHARMACEUTICALS INC's ticker is XFOR and the CUSIP is 98420X103. A total of 63 filers reported holding X4 PHARMACEUTICALS INC in Q1 2021. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $7,775,531 | -43.8% | 7,133,515 | 0.0% | 0.16% | -34.3% |
| Q2 2023 | $13,839,019 | +173.4% | 7,133,515 | +22.6% | 0.25% | +153.5% |
| Q1 2023 | $5,061,422 | -12.4% | 5,817,726 | 0.0% | 0.10% | -10.8% |
| Q4 2022 | $5,777,002 | -32.8% | 5,817,726 | +15.7% | 0.11% | -30.6% |
| Q3 2022 | $8,596,000 | +548.3% | 5,026,817 | +265.9% | 0.16% | +566.7% |
| Q2 2022 | $1,326,000 | -44.8% | 1,373,849 | 0.0% | 0.02% | -38.5% |
| Q1 2022 | $2,404,000 | -23.6% | 1,373,849 | 0.0% | 0.04% | -2.5% |
| Q4 2021 | $3,146,000 | -56.7% | 1,373,849 | 0.0% | 0.04% | -50.0% |
| Q3 2021 | $7,268,000 | -18.6% | 1,373,849 | 0.0% | 0.08% | -11.1% |
| Q2 2021 | $8,930,000 | -24.5% | 1,373,849 | 0.0% | 0.09% | -18.9% |
| Q1 2021 | $11,829,000 | +69.3% | 1,373,849 | +26.4% | 0.11% | +82.0% |
| Q4 2020 | $6,986,000 | -5.0% | 1,086,493 | 0.0% | 0.06% | -33.7% |
| Q3 2020 | $7,356,000 | -27.4% | 1,086,493 | 0.0% | 0.09% | -35.7% |
| Q2 2020 | $10,126,000 | -6.8% | 1,086,493 | 0.0% | 0.14% | -21.9% |
| Q1 2020 | $10,865,000 | -6.5% | 1,086,493 | 0.0% | 0.18% | +10.2% |
| Q4 2019 | $11,625,000 | -2.3% | 1,086,493 | +16.0% | 0.17% | -26.5% |
| Q3 2019 | $11,903,000 | -15.3% | 936,493 | 0.0% | 0.23% | +3.7% |
| Q2 2019 | $14,047,000 | +159.0% | 936,493 | +200.6% | 0.22% | +159.5% |
| Q1 2019 | $5,423,000 | – | 311,493 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Polaris Venture Management Co. V, L.L.C. | 311,492 | $2,682,000 | 3.48% |
| Sio Capital Management, LLC | 804,597 | $6,928,000 | 1.41% |
| Bain Capital Life Sciences Investors, LLC | 2,119,540 | $18,249,000 | 1.03% |
| SV Health Investors, LLC | 311,490 | $2,682,000 | 1.00% |
| Monashee Investment Management LLC | 574,712 | $4,948,000 | 0.76% |
| Ikarian Capital, LLC | 2,614,988 | $22,515,000 | 0.76% |
| Abingworth LLP | 229,885 | $1,956,000 | 0.68% |
| New Leaf Venture Partners, L.L.C. | 335,000 | $2,884,000 | 0.67% |
| BVF INC/IL | 1,091,579 | $9,398,000 | 0.35% |
| Endurant Capital Management LP | 151,996 | $1,309,000 | 0.34% |